Navigation Links
OriGene Announces 37,000 ORF cDNA Clones in a GFP Vector

ROCKVILLE, Md., Oct. 31 /PRNewswire/ -- OriGene Technologies, Inc. announces its flagship products, TrueORF cDNA clones, are available now in a GFP (green fluorescence protein) vector, enabling easy transfection monitoring and protein expression. With this launch, over 25,000 human ORF (open reading frame) clones and 12,000 mouse ORF clones can be ordered in pCMV-tGFP vector.

In early October, the 2008 Nobel Prize in chemistry was awarded to the three scientists who discovered GFP protein. They are Drs. Martin Chalfie of Columbia University, Roger Y. Tsien of the University of California at San Diego, and Osamu Shimomura of the Marine Biology Laboratory in Woods Hole, MA. It is because of their outstanding work in discovering and developing GFP that we are able to turn GFP into a powerful tool for protein expression and cellular biology. With comprehensive TrueORF cDNA clones, researchers can now co-express specific gene with GFP to monitor protein expression level, detect exact cellular location, and study protein-protein interaction. As a leading full length cDNA clone provider, OriGene is committed to providing expanded utilities for these clones in life science research and drug discovery.

About OriGene

Based in Rockville, Maryland, OriGene Technologies, Inc. pioneered the development of patented processes for the isolation of full-length cDNA, and commercialized an extensive gene bank of authentic full-length cDNA clones. In addition to cDNA clones, OriGene offers unique gene expression products such TissueScan cancer qPCR arrays for biomarker discovery and validation. OriGene is committed to its mission to be "Your Gene Company", in supplying everything a researcher would need for gene based research.

To learn more about OriGene Technologies, Inc., and its products, visit

For more information on this announcement, please contact:

Walter Tian


OriGene Technologies


SOURCE OriGene Technologies Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Sharps Compliance Corp. Announces Appointment of John R. Grow as President and Chief Operating Officer
2. BMP Sunstone Announces Participation in November Investor Conferences
3. American Oriental Bioengineering Announces Participation in November Investor Conferences
4. AVAX Technologies, Inc. Announces Closing of Bridge Loan Financing
5. Medarex Announces 2008 Third Quarter Financial Results
6. Halozyme Therapeutics Announces Conference Call on November 6 to Review Third Quarter Results
7. Cytochroma announces appointment of Ulrik Spork to Board of Directors
8. Medizone International, Inc. Announces Establishment of Canadian Foundation for Global Health
9. Insmed Announces Financial Results for Third Quarter and Nine-Months Ended September 30, 2008
10. STERIS Corporation Announces Fiscal 2009 Second Quarter and First Half Results
11. Telik Announces Top-Line Results From Assist-5 Trial of Telcyta(R) in Combination With Pegylated Liposomal Doxorubicin in Platinum Refractory and Resistant Ovarian Cancer
Post Your Comments:
(Date:11/27/2015)... 27, 2015 /PRNewswire/--  Mallinckrodt plc (NYSE: MNK ... it has closed the sale of its global contrast ... NYSE Euronext) in a transaction valued at approximately $270 ... and a total of approximately 1,000 employees spread across ... St. Louis area. This entire workforce and ...
(Date:11/27/2015)... 27, 2015 ... of companion diagnostics is one of the ... with pharmaceutical companies and diagnostic manufacturers working ... . --> ... on global cancer biomarkers market spread across ...
(Date:11/26/2015)... , England , November 26, 2015 ... Lightpoint Medical, an innovative medical device company specializing in imaging ... grant from the European Commission as part of the Horizon ... the company to carry out a large-scale clinical trial in ... -->      (Logo: , --> ...
(Date:11/25/2015)... 25, 2015  PharmAthene, Inc. (NYSE MKT: PIP) announced ... stockholder rights plan (Rights Plan) in an effort to ... (NOLs) under Section 382 of the Internal Revenue Code ... PharmAthene,s use of its NOLs could be substantially limited ... in Section 382 of the Code. In general, an ...
Breaking Biology Technology:
(Date:11/12/2015)... , Nov. 12, 2015  Arxspan has ... of MIT and Harvard for use of its ... information management tools. The partnership will support the ... biological and chemical research information internally and with ... be used for managing the Institute,s electronic laboratory ...
(Date:11/10/2015)... Nov. 10, 2015  In this report, ... basis of product, type, application, disease indication, ... this report are consumables, services, software. The ... safety biomarkers, efficacy biomarkers, and validation biomarkers. ... are diagnostics development, drug discovery and development, ...
(Date:11/9/2015)... , Nov. 9, 2015  Synaptics Inc. (NASDAQ: ... today announced broader entry into the automotive market with ... match the pace of consumer electronics human interface innovation. ... are ideal for the automotive industry and will be ... Europe , Japan ...
Breaking Biology News(10 mins):